New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Using algorithms to track down cancer

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p
Oncology May 11,2024
Using algorithms to track down cancer

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p
Oncology May 11,2024
Made to measure sugar-like molecule could improve cancer-fighting antibodies

Made to measure sugar-like molecule could improve cancer-fighting antibodies

by Canadian Glycomics NetworkDr. Robert Britton in his Simon Fraser University lab in Burnaby, BC. Credit: B. Poitras, GlycoNetDr. Robert Britton firmly believes every molecule is important. This chem
Oncology May 11,2024
Made to measure sugar-like molecule could improve cancer-fighting antibodies

Made to measure sugar-like molecule could improve cancer-fighting antibodies

by Canadian Glycomics NetworkDr. Robert Britton in his Simon Fraser University lab in Burnaby, BC. Credit: B. Poitras, GlycoNetDr. Robert Britton firmly believes every molecule is important. This chem
Oncology May 11,2024
Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for
Oncology May 11,2024
Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for
Oncology May 11,2024
Nutritional cues regulate pancreatic tumor's 'cell drinking'

Nutritional cues regulate pancreatic tumor's 'cell drinking'

by Sanford Burnham Prebys Medical Discovery InstituteCosimo Commisso, Ph.D., assistant professor in Sanford Burnham Prebys' NCI-designated Cancer Center. Credit: Sanford Burnham PrebysDespera
Oncology May 11,2024
Nutritional cues regulate pancreatic tumor's 'cell drinking'

Nutritional cues regulate pancreatic tumor's 'cell drinking'

by Sanford Burnham Prebys Medical Discovery InstituteCosimo Commisso, Ph.D., assistant professor in Sanford Burnham Prebys' NCI-designated Cancer Center. Credit: Sanford Burnham PrebysDespera
Oncology May 11,2024
Treating tumors with engineered dendritic cells

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center
Oncology May 11,2024
Treating tumors with engineered dendritic cells

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center
Oncology May 11,2024
Premature death of autistic people in the UK investigated for the first time

Premature death of autistic people in the UK investigated for the first time

by University College LondonCredit: Unsplash/CC0 Public DomainA new study led by University College London researchers confirms that autistic people experience a reduced life expectancy; however,
Oncology May 11,2024
Premature death of autistic people in the UK investigated for the first time

Premature death of autistic people in the UK investigated for the first time

by University College LondonCredit: Unsplash/CC0 Public DomainA new study led by University College London researchers confirms that autistic people experience a reduced life expectancy; however,
Oncology May 11,2024
The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

by ElsevierObesity is associated with increased risk of developing and dying from the following cancers: breast (in postmenopausal women), ovarian, liver, gallbladder, kidney (renal cell), colon,
Oncology May 11,2024
The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

The connection between diet, obesity, and cancer: Nutrition experts explore the evidence

by ElsevierObesity is associated with increased risk of developing and dying from the following cancers: breast (in postmenopausal women), ovarian, liver, gallbladder, kidney (renal cell), colon,
Oncology May 11,2024
Prostate cancer drug given initial 'no' for NHS in England

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In
Oncology May 11,2024
Prostate cancer drug given initial 'no' for NHS in England

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In
Oncology May 11,2024
Fighting cancer with nanobodies and computer simulations

Fighting cancer with nanobodies and computer simulations

by Catherine Collins,Horizon: The EU Research & Innovation MagazineResearchers in the Netherlands are hoping to move vaccine therapy from the lab to inside the body. Credit: Unsplash/Drew Ha
Oncology May 11,2024
Fighting cancer with nanobodies and computer simulations

Fighting cancer with nanobodies and computer simulations

by Catherine Collins,Horizon: The EU Research & Innovation MagazineResearchers in the Netherlands are hoping to move vaccine therapy from the lab to inside the body. Credit: Unsplash/Drew Ha
Oncology May 11,2024
When should NHS contact patients over faulty genes?

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre
Oncology May 11,2024
When should NHS contact patients over faulty genes?

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre
Oncology May 11,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com